Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: Results Through 24 Months From a Phase 1 Study

              Author:Sarva, Harini   Henchcliffe, Claire   Lozano, Andres   Fasano, Alfonso   Kalia, Suneil   Yu, Kenny Kwok Hei   Brennan, Cameron   Floro, Nicole   Stemple, Whitney   Abid, Nauman   Tabar, Viviane   

              Session Name:S37: Movement Disorders: Clinical Trials  

              Topic:Movement Disorders  

              Program Number:S37.005  

              Author Institution:Department of Neurology, Weill Cornell Medicine, New York, NY, USA, New York, NY  Department of Neurology, University of California, Irvine, CA, USA, Orange, CA  Department of Neurosurgery and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, New York, NY  BlueRock Therapeutics LP, Cambridge, MA, USA, Cambridge, MA